The BCG Shortage-Reference-Cited by-同舟云学术

The BCG Shortage

Published:2017-07-27 Issue:3 Volume:3 Page:227-228
ISSN:2352-3727
Container-title:Bladder Cancer
language:
Short-container-title:BLC

Author:

Messing Edward M.¹

Affiliation:

1. University of Rochester Medical Center, Rochester, NY, USA

Publisher

IOS Press

Subject

Urology,Oncology

Reference7 articles.

1. Response to “Drug shortages and the burden of access to care: A critical issue affecting patients with cancer”;Zweig;Clin J Oncol Nurses,2014

2. Cherici C , McGinnis P , Russell W . Buyer beware: Drug shortages and the gray market. Retrieved from http://www.premierinc.com/about/news/11-aug/Gray-Market/Gray-Market-Analysis-08152011.pdf

3. The shortage of essential chemotherapy drugs in the United States;Gatesman;NEJM,2011

4. Ensuring access to injectable generic drugs – the case of intravesical BCG for bladder cancer;Davies;NEJM,2017

5. The burden of bladder cancer in men and women: Analysis of the years of life lost;Scosyrev;BJU Int,2012

Cited by 50 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Sequential endoluminal gemcitabine and docetaxel for the treatment of clinically non-invasive high-grade upper tract urothelial carcinoma;Urologic Oncology: Seminars and Original Investigations;2024-01

2. Definitions, End Points, and Clinical Trial Designs for Bladder Cancer: Recommendations From the Society for Immunotherapy of Cancer and the International Bladder Cancer Group;Journal of Clinical Oncology;2023-12-10

3. Variation in Statewide Intravesical Treatment Rates for Non-Muscle Invasive Bladder Cancer During the Bacillus Calmette-Guerin Drug Shortage;Urology;2023-07

4. Comparison of Sequential Intravesical Gemcitabine and Docetaxel vs Bacillus Calmette-Guérin for the Treatment of Patients With High-Risk Non–Muscle-Invasive Bladder Cancer;JAMA Network Open;2023-02-28

5. Instrumental dead space and proximal working channel connector design in flexible ureteroscopy: a new concept;Therapeutic Advances in Urology;2023-01